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Cortical abnormalities are considered a neurobiological characteristic of schizophrenia. However,
the pattern of such deficits as they progress over the illness remains poorly understood. The goal
of this project was to assess the progression of cortical thinning in frontal and temporal cortical
regions in schizophrenia, and determine whether relationships exist between them and
neuropsychological and clinical symptom profiles. As part of a larger longitudinal 2-year followup study, schizophrenia (n=20) and healthy participants (n=20) group-matched for age, gender,
and recent-alcohol use, were selected. Using MRI, estimates of gray matter thickness were derived
from primary anatomical gyri of the frontal and temporal lobes using surface-based algorithms.
These values were entered into repeated-measures analysis of variance models to determine group
status and time effects. Change values in cortical regions were correlated with changes in
neuropsychological functioning and clinical symptomatology. Results revealed exaggerated
cortical thinning of the middle frontal, superior temporal, and middle temporal gyri in
schizophrenia participants. These thickness changes strongly influenced volumetric reductions, but
were not related to shrinking surface area. Neuropsychological and clinical symptom profiles were
stable in the schizophrenia participants despite these neuroanatomic changes. Overall it appears
ongoing abnormalities in the cerebral cortex continue after initial onset of schizophrenia,
particularly the lateral aspects of frontal and temporal regions, and do not relate to
neuropsychological or clinical measures over time. Maintenance of neuropsychological
performance and clinical stability in the face of changing neuroanatomical structure suggests the
involvement of alternative compensatory mechanisms.
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INTRODUCTION
1.1
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Schizophrenia is currently conceptualized as a neurobiological disorder that develops in
concert with disturbances in the formation of neural structures (Keshavan et al., 2008).
While the specific neuroanatomical framework of the illness has been investigated for many
years (Kraepelin, 1919), its precise pattern and evolution over time remains elusive. Current
research in this area has focused on determining the timing and trajectory of changes in
specific neuroanatomical structures as schizophrenia patients enter their first psychotic
episode and then between subsequent psychotic relapses. Longitudinal changes in total brain
volume and corresponding ventricular enlargement are the most consistent findings (DeLisi
et al., 2004; Kempton et al., 2010; van Haren et al., 2008), and in a meta-analytic review,
Olabi and colleagues (2011) determined that progressive reductions in frontal lobe gray
matter volume, followed by frontal, parietal, and temporal lobe white matter volume were
the most common across studies. In contrast, the localization of changes within specific
lobular subregions is less reliable (DeLisi, 2008), with some, but not all, studies reporting
gradual loss in frontal and temporal areas, particularly the superior temporal gyrus and
medial frontal regions (Hulshoff Pol & Kahn, 2008; Kasai et al., 2003). Such disparities may
occur because of differences across the investigation of illness phase (DeLisi, 2008); thus
the question of “where” changes occur may depend on “when” in the course of illness the
participants are studied.
Attempts have also been made to correlate cortical gray matter loss in schizophrenia with
changes in cognition given the presence of neuropsychological deficits and their known
associations between various brain regions (Antonova et al., 2004). While the presence of
premorbid cognitive deficits (Bilder et al., 2006), and occurrence of further decline after
initial onset have been reported (Seidman et al., 2006), current evidence also strongly
indicates that cognitive impairment appears to be stable after the first episode of illness
(Heaton et al., 2001; Hill et al., 2004). Consequently, the presence of stable cognitive
deficits in the face of progressive changes in brain structure during the chronic phase of
schizophrenia is puzzling, and deserves confirmation and further investigation.
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1.2
For the current study, we used semi-automated surface-based methods to examine whether
changes in specific subregions of the frontal and temporal lobe would occur over a 2-year
period in schizophrenia patients (SCZ) and healthy controls (CON), and whether such
changes would be correlated with changes in neuropsychological performance and
psychopathology. Based on the assertion that reductions in cortical thickness would be the
primary manner in which gray matter loss would be observed (van Haren et al., 2011), we
hypothesized that SCZ, but not CON, participants would show significant cortical thickness
reductions over time in frontal and temporal lobes, particularly the middle frontal and
superior temporal gyri. This hypothesis is based on consistent evidence for abnormalities in
these subregions in schizophrenia and their involvement in cognitive functions (Harms et al.,
2010; Qiu et al., 2007; Takahashi et al., 2009; van Haren et al., 2007). Second, in an
exploratory fashion, we assessed the relationship between longitudinal changes in cortical
thickness and the severity of neuropsychological deficits and psychopathology, again
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because of prior findings in the literature suggesting that changes in the cortex are related to
such impairments in schizophrenia (Andreasen et al., 2011; Ho et al., 2003).
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METHODS
2.1 Participants
Participants were selected from larger groups recruited as part of an ongoing study of
schizophrenia. Beginning with groups of participants that returned for at least one follow-up
assessment, (SCZ = 38, CON = 27), we selected subsets of participants group-matched for
age, gender, and recent alcohol use based on findings that alcohol use may exacerbate gray
matter loss in schizophrenia (Smith et al., 2011), and excluded age outliers that were
younger than 17 and older than 65. Participants were excluded if they met DSM-IV criteria
for mental retardation, substance abuse (moderate or severe) or dependence (any type) at
present time or during the past 6 months. Informed consent was obtained from each subject
after a complete description of the study was given.
2.2 Clinical Measures
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All participants were assessed using the Structured Clinical Interview for DSM-IV Axis I
Disorders (First et al., 1996), to determine the presence of a current diagnosis of
schizophrenia and a lifetime history of substance abuse or dependence. Recent alcohol use
was measured as the quantity of alcohol consumed over two years prior to baseline using a
semi-structured interview (Skinner, 1982; Sullivan et al., 1995). We also examined cigarette
consumption as a potential confound given that nicotine use has been related to reduced gray
matter density (McClernon, 2009) and the vast majority of schizophrenia patients have
nicotine dependence (Van Dongen, 1999). See Table 1 for detailed demographic data.
Psychopathology and neuropsychological functioning were assessed as previously described
(Smith et al., 2009). A battery of neuropsychological measures that correspond with tasks
relevant to cognition in schizophrenia was administered (Nuechterlein et al., 2004). These
scores were then averaged to form composite domain scores in four areas of cognitive
functioning – crystallized IQ (IQ), working memory (WM), episodic memory (EM), and
executive functioning (EF). Psychopathology was assessed using the Scale for the
Assessment of Negative Symptoms (Andreasen, 1983), and the Scale for the Assessment of
Positive Symptoms (Andreasen, 1984), for which three symptom clusters were quantified –
positive, negative, and disorganized. Raw and scaled scores for all measures were
transformed to z-scores using data from a previously published and overlapping reference
group (Smith et al., 2009). All schizophrenia participants were assessed during treatment
and after they had attained clinical stability for several weeks.
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2.3 MRI Acquisition Parameters and Data Processing
MR scans were acquired at both baseline and 2-year follow-up visits using a 1.5T Vision
scanner (Siemens Medical Systems) with actively shielded gradients and echo-planar
capability. All scans were collected using an MPRAGE sequence (TR = 10ms, TE = 4ms,
Flip angle = 30°, ACQ = 1, Matrix = 256 × 256, Scanning time = 5.6 minutes) that acquired
3D datasets with 1 mm x 1 mm x 1.25mm resolution.
MPRAGE images were analyzed and processed using the longitudinal pipeline from
FreeSurfer (FS) release 4.5.0 (Dale et al., 1999), which is documented and freely available
for download online (http://surfer.nmr.mgh.harvard.edu). Any geometric inaccuracies or
topological defects were corrected using a combination of automatic and manual methods
(Segonne et al., 2007). Manual editing was carefully conducted according to established
guidelines. Reconstruction of the white and pial surfaces was required for estimation of
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cortical measures. Algorithms in the FS longitudinal processing pipeline reduce intra-subject
morphological variability that can occur in image registration, intensity normalization, and
iterative processes that approximate the cortical surface (Reuter et al., 2010).
Considering prior work to localize neuroanatomical changes in schizophrenia (see above),
12 a priori regions of interest (ROIs), 6 per hemisphere, in the frontal and temporal lobes
were selected for study (see Supplemental Figure). Definitions of these ROIs were based on
modifications to the standard FS parcellation atlas (Desikan et al., 2006), by combining
previously defined subregions into main gyri found in the frontal and temporal lobes. These
regions are as follows:
•

Superior Frontal Gyrus (SFG) – superior frontal

•

Middle Frontal Gyrus (MFG) – caudal middle frontal, rostral middle frontal

•

Inferior Frontal Gryus (IFG) – pars opercularis, pars triangularis, pars orbitalis

•

Superior Temporal Gyrus (STG) – transverse temporal region, superior temporal,
banks of the superior temporal sulcus

•

Middle Temporal Gyrus (MTG) – middle temporal

•

Inferior Temporal Gyrus (ITG) – inferior temporal

NIH-PA Author Manuscript

Estimates of cortical gray matter thickness (mm), volume (mm3), and surface area (mm2)
were calculated for each of these regions using embedded FS algorithms.
2.4 Statistical Analyses
Cortical thickness values were entered into repeated-measures analysis of variance (RMANOVA) models, testing the main effects of group (between subject factor), hemisphere,
and time (within subject factors), and then group-by-time interactions. To examine change
in cognition and psychopathology over time, scores from the composite domains at baseline
and follow-up were entered into RM-ANOVA models, with group status as the main effect
(cognition and psychopathology models), and time as a repeated factor (psychopathology
model only). To control for multiple comparisons, the False Discovery Rate (FDR)
procedure outlined by Benjamini and colleagues (2001), which accounts for the expected
proportion of rejected hypotheses that are falsely rejected, was utilized. Secondary RMANOVA analyses on cortical volume and surface area were also conducted.
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Scores representing a measure of change over time (i.e., slopes) were calculated for all
variables as: follow-up – baseline = change score. Pearson correlations between change
scores in cortical thickness with volume and surface area were conducted within each
significant ROI to determine the relative influence on each measure. Pearson models were
also used to correlate cognitive change scores with key cortical regions known to support
their functions, these were designed as: frontal gyri with WM, EF, IQ; and temporal gyri
with EM, IQ. Further investigation involved additional correlation models on baseline
measurements for these variables. The influence of interval medication use, duration of
illness (DOI), and nicotine use on cortical progression was assessed through Pearson
correlations between these variables and rates of cortical thickness change in the identified
ROIs. Corrections for multiple comparisons were not utilized due to their exploratory
nature.
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RESULTS
3.1 Longitudinal Cortical Thickness Changes in Frontal and Temporal Lobe Structures
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Mean and standard deviation values with percent change for each structure are presented in
Table 2. Findings from RM-ANOVA models of cortical thickness in the frontal lobes
revealed significant effects for time in the SFG, MFG, and IFG (Table 3). Group-by-time
interactions that survived FDR correction were observed only in the MFG. The effect of
hemisphere was significant for the SFG (L > R: F1,38 = 56.42, p < 0.001), and IFG (R > L:
F1,38 = 12.9, p = 0.001) only. In the temporal lobes, RM-ANOVA models revealed a
significant main effect for time in the STG, and group-by-time interaction effects in the STG
and MTG that survived FDR correction (Table 3). There was a significant main effect for
hemisphere only in the ITG (L > R: F1,38 = 12.07, p = 0.001). Scatterplots of baseline and
follow-up values are shown in Figure 1. Secondary analyses of cortical volume and surface
area for frontal and temporal regions revealed only trend group-by-time interactions for
SFG, MFG, STG, and MTG volume (see Supplemental Table).
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Pearson models between change scores in cortical thickness with volume and surface area
were conducted within the MFG, STG, and MTG for SCZ subjects (Table 4). Cortical
thickness correlations were highly significant with change in volume (all p < 0.001)
compared to those with surface area. Pearson models between DOI, interval antipsychotic
medication use (both first and second generation chlorpromazine equivalents), and nicotine
use with cortical thickness change scores of all frontal and temporal ROIs revealed no
significant correlations at p < 0.05.
3.3 Longitudinal Changes in Neuropsychological Performance and Clinical Symptoms
Significant main group effects were noted on every neuropsychological domain, including
IQ, WM, EM, and EF (see Table 5). However, there were no main effects for time, or groupby-time interactions. Longitudinal analyses of clinical symptom domains in SCZ subjects
revealed no main effects of time.
3.4 Correlations with Neuropsychological Performance and Clinical Symptoms at Baseline
and Over Time
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Pearson correlations between baseline measurements of ROI cortical thickness and cognitive
variables in SCZ subjects revealed strong positive relationships between IQ and the left STG
(r = 0.612, p = 0.002) and EF with both the left (r = 0.570, p = 0.009) and right (r = 0.590, p
= 0.006) IFG indicating poorer cognitive performance as cortical thickness in these regions
decreases. There were no significant correlations with measurements of EM and WM. With
regard to clinical symptoms, strong negative correlations with disorganization and the right
IFG (r =-0.486, p = 0.030), and left STG (r = −0.457, p = 0.043) were observed, indicating
symptom increase as cortical thickness in these regions decrease. No significant
relationships emerged for positive and negative symptomatology.
Correlations between cortical thickness ROI change scores and cognitive change scores
yielded no significant findings. When examining relationships between cortical ROI and
clinical symptom change scores, a trend correlation between decreased right hemisphere
STG and an increase in disorganized symptoms (r = −0.450, p = 0.047) was observed.

DISCUSSION
4.1
In this study, we investigated the progression of frontal and temporal cortical gray matter
thickness abnormalities in schizophrenia and attempted to relate these to changes in
Schizophr Res. Author manuscript; available in PMC 2013 August 01.
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cognitive performance and symptom expression. Our findings suggest that schizophrenia
subjects have exaggerated cortical thinning in selected subregions of both frontal and
temporal lobes that occurs over a period of 2 years. In particular, the most extensive loss in
cortical thickness was detected in the MFG, STG, and MTG. Furthermore, it was determined
that these changes in thickness form the basis of longitudinal cortical volume loss, while
unrelated to changes in surface area. Interestingly, despite progressive loss in cortical
structure, neuropsychological performance and psychopathology severity remained stable in
our schizophrenia subjects over this same 2-year period.
Broadly, our results are in agreement with other studies that have reported gray matter
deterioration in both the frontal and temporal cortex in schizophrenia (Andreasen et al.,
2011; Ho et al., 2003; Olabi et al., 2011; van Haren et al., 2007). In particular, our STG
findings are very similar to those in longitudinal studies using voxel-based image analysis
methods in high risk populations (Job et al., 2005; Takahashi et al., 2009), as well as firstepisode patients (Asami et al., 2012), suggesting this area is principally involved in the
pathophysiology of the disease. Furthermore, a recent longitudinal study of cortical
thickness by van Haren and colleagues (2011) discovered excessive thinning over time in
STG and MTG regions. Interesting, they also found changes in anterior portions of the
MFG, which coincides with our results.
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As volume is the product of thickness and surface area in a “carpet-like” structure, such as
the cerebral cortex, changes in volume would be the result of changes in one or both of these
two sources. Indeed, this was evident in our own findings with associations observed
between these measurements and progressive volume loss. Particularly, our assertion that
volume loss would be mainly attributable to thinning of the cortex held true as these
measures were highly related across regions with significant change over time. Van Haren
and colleagues (2011) work also supports our data as strong relationships between
progressive cortical thinning and volume change were found in their schizophrenia cohort.
Cortical abnormalities in schizophrenia are believed to be primarily due to
neuropathological changes such as shrinkage of the neuropil and increased neuronal density
without the gliosis observed in neurodegenerative conditions (Goldman-Rakic & Selemon,
1997; Selemon et al., 1995). It has been hypothesized that two different neurodevelopmental
mechanisms could explain this phenomenon, one that involves excessive pruning that begins
in adolescence and extends till illness onset, and one that begins after onset and
characterized by diminished neuroplasticity (Andreasen et al., 2011). This latter process
would be a likely candidate for the cortical thinning observed in our post-onset
schizophrenia subjects.
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Both frontal and temporal lobes have been implicated in a number of cognitive processes
affected in schizophrenia (Antonova et al., 2004), including attention, language, working
memory, and various aspects of executive functioning, as well as with the expression of
different clinical symptoms (Perlstein et al., 2001; Shenton et al., 1992). Our findings
reinforce the notion of stable impaired neuropsychological profiles in schizophrenia (Albus
et al., 2002; Heaton et al., 2001), but also demonstrate that this phenomenon can exist
despite the progression of cortical thinning observed in these same individuals. Moreover,
our failure to find support for correlated changes in neuroanatomical structure and cognition
should be considered in the context of relationships between these same sets of variables at
baseline. The lack of a longitudinal association suggests a more complex relationship
between the capacity for cognitive performance and the integrity of cortical structure over
the course of illness in schizophrenia. Perhaps to fully understand structure-function
relationships over time in schizophrenia, one must consider an integrated approach with the
involvement of other types of structures, such as white matter pathways or subcortical
regions.
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Consideration should also be given to compensatory mechanisms that may develop to
maintain cognition in the face of changes in neuroanatomical structures known to support
these same functions. The functional imaging literature in schizophrenia has suggested that
the recruitment and engagement of alternative neural circuits, particularly neighboring
regions, can occur to aid performance in schizophrenia patients that is comparable to that of
healthy subjects (Quintana et al., 2003; Tan et al., 2006). For example, Murray and
colleagues (2010) found that associative learning in schizophrenia stimulated activation of
the frontal pole, anterior cingulate, visual, and parietal cortex, all areas outside of prefrontal
regions that are activated in healthy subjects. Thus, the recruitment of additional structures
and circuits may also occur to sustain performance, while the structural integrity of primary
regions declines.
4.2
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There were several limitations to the study. First, our sample sizes were small, thus needing
replication with larger numbers, especially in groups of subjects from specific stages of the
illness, to determine whether our findings are specific to a particular illness phase. However,
our ability to carefully group-match subjects based on age, gender, and recent alcohol use
may have compensated for some of the loss in statistical power. Additionally, despite the
relationships between neuroanatomical and cognitive measures at baseline, our failure to
find relationships between these measures over time may be the result of the inadequacy of
our method for detecting subtle changes in cognitive performance. Further localization of
time-dependent cortical changes in other regions would also be of future interest.
In conclusion, our results suggest that progressive changes in the frontal and temporal cortex
occur in individuals with schizophrenia after the onset of the acute phase of their illness.
Moreover, the maintenance of cognitive performance and clinical stability in the face of this
structural advancement suggests that compensatory mechanisms may be available to
preserve neural function. Our findings also inform current theories that the pathogenesis of
schizophrenia includes a progressive component, which may be influenced by genetic and
environmental factors throughout the course of the disease (Harrison & Weinberger, 2005;
Rapoport et al., 2005).

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Scatterplots demonstrating cortical thickness changes for selected ROIs in both healthy
control (CON) and schizophrenia (SCZ) subjects at baseline (TP1) and follow - up (TP2)
time points.
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